Therapeutic strategies for COVID-19: progress and lessons learned
Guangdi Li, Rolf Hilgenfeld, Richard J. Whitley, Erik De Clercq
Topics & Concepts
TocilizumabDrug repositioningPandemicMedicineRepurposingCoronavirus disease 2019 (COVID-19)CoronavirusClinical trialRitonavirDrug developmentDrugSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discoveryVirologyPharmacologyIntensive care medicineInfectious disease (medical specialty)DiseaseVirusBioinformaticsViral loadBiologyInternal medicineEcologyAntiretroviral therapySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesPARP inhibition in cancer therapy